GSK
740 hedge funds and large institutions have $9.83B invested in GSK in 2017 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 288 increasing their positions, 251 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
5% less funds holding
Funds holding: 778 → 740 (-38)
9% less funds holding in top 10
Funds holding in top 10: 11 → 10 (-1)
41% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 71
Holders
740
Holding in Top 10
10
Calls
$130M
Puts
$79M
Top Buyers
| 1 | +$602M | |
| 2 | +$132M | |
| 3 | +$101M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$39.1M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$34.2M |
Top Sellers
| 1 | -$208M | |
| 2 | -$94.9M | |
| 3 | -$79.9M | |
| 4 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$49.9M |
| 5 |
Jane Street
New York
|
-$33M |